Additionally, activation of CB1R signaling in adipose tissue and in the liver causes obesity and metabolic complications, including insulin resistance and dyslipidemia by increasing fatty acid uptake, lipogenesis, and adipogenesis [8] (Figure 2). This evidence concerns the gene CNR1 and metabolic syndrome.